Condition
Uterine Neoplasms clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Uterine Neoplasms clinical trials that are recruiting, at sites in 6 countries (most in Italy (2), United Kingdom (1), China (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 6Countries
Newest Uterine Neoplasms clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Oral Progestin Tablets With Radiotherapy vs. Standard Radiotherapy and Chemotherapy in High-Risk NSMP Endometrial Cancer | Phase 3 | Bath and 11 other locations | Recruiting | Sep 21, 2026 |
| AI into Ultrasound Diagnostics in Reproductive Medicine | — | Budapest, Budapest | Recruiting | Sep 9, 2026 |
| Ultrasound changes in fibroids during relugolix‑estradiol‑norethisterone treatment. | — | Roma | Recruiting | May 1, 2025 |
| Evaluating radiation treatment outcomes for uterine cancer | — | Bologna | Recruiting | Jan 14, 2025 |
| Examining the effects of brachytherapy on gynecological cancers | — | Hangzhou, Zhejiang | Recruiting | Feb 16, 2022 |
| Using reminders and self-sampling to boost cervical cancer screening participation | — | Luleå, Norrbotten County and 5 other locations | Recruiting | Aug 20, 2019 |
| Optimizing treatment models for uterine cancers | — | Tübingen | Recruiting | Aug 10, 2018 |
All recruiting trials (7)
-
Oral Progestin Tablets With Radiotherapy vs. Standard Radiotherapy and Chemotherapy in High-Risk NSMP Endometrial Cancer
This trial tests whether adding oral progestin tablets after radiotherapy is as effective as the standard radiotherapy plus chemotherapy for high-risk NSMP endometrial cancer, hoping to reduce side effects and improve quality of life.
-
AI into Ultrasound Diagnostics in Reproductive Medicine
Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.
-
Ultrasound changes in fibroids during relugolix‑estradiol‑norethisterone treatment.
This project will see if relugolix‑estradiol‑norethisterone changes the ultrasound appearance of fibroids in premenopausal women with heavy menstrual bleeding.
-
Evaluating radiation treatment outcomes for uterine cancer
This study looks at how different radiation treatments for uterine cancer affect patients and their side effects to help make treatments better in the future.
-
Examining the effects of brachytherapy on gynecological cancers
This study looks at how well brachytherapy works for women aged 18 to 80 with different types of gynecological cancers.
-
Using reminders and self-sampling to boost cervical cancer screening participation
This study is testing if sending text reminders and using self-sampling kits can help women at high risk for cervical cancer get screened more often.
-
Optimizing treatment models for uterine cancers
This study is testing new ways to create personalized treatment plans for patients with uterine cancer who are having surgery to see if it can improve their outcomes.
Related topics
Quick answers
How many Uterine Neoplasms clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Italy (2 trials), United Kingdom (1 trial), China (1 trial), Sweden (1 trial), Hungary (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.